A significant correlation was found between ADM mRNA expression and clinicopathological stages in thyroid carcinoma (THCA), pancreatic adenocarcinoma (PAAD), lung adenocarcinoma (LUAD), liver hepatocellular carcinoma (LIHC), kidney renal papillary cell carcinoma (KIRP), and head and neck squamous cell carcinoma (HNSC) (p<0.05) (Figure 2C). This evidence concerns the gene ADM and thyroid gland carcinoma.